NewAmsterdam Pharma News

20-F/A: Registration statement / Annual report / Transition report (Amendment)

Oct 28 20:04

8-K: Current report

Oct 19 04:54

4: Statement of changes in beneficial ownership of securities-Officer Davidson Michael H.

Oct 12 05:04

4: Statement of changes in beneficial ownership of securities-Officer Kooij Louise Frederika

Oct 2 05:26

144: Notice of proposed sale of securities pursuant to Rule 144

Oct 2 05:15

4: Statement of changes in beneficial ownership of securities-Officer Audet Juliette Berangere

Oct 1 05:23

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Aug 24 04:22

4: Statement of changes in beneficial ownership of securities-Officer Davidson Michael H.

Aug 23 04:36

EFFECT: Others

Aug 13 18:05

POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Aug 10 05:28

8-K: Current report

Aug 10 05:28

424B5: Prospectus

Aug 10 05:23

10-Q: Q2 2024 Earnings Report

Aug 7 20:01

8-K: NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

Aug 7 20:01

8-K: Current report

Jul 29 20:34

4: Statement of changes in beneficial ownership of securities-Director McKenna Mark C.

Jul 20 04:36

3: Initial statement of beneficial ownership of securities-Director McKenna Mark C.

Jul 20 04:32

3: Initial statement of beneficial ownership of securities-Director Joustra Wouter

Jul 20 04:32

8-K: Current report

Jul 18 20:16

EFFECT: Others

Jul 15 18:24